Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 30, 2023

SELL
$32.09 - $37.51 $3.24 Million - $3.78 Million
-100,837 Reduced 33.03%
204,490 $6.78 Million
Q2 2023

Aug 10, 2023

BUY
$36.12 - $41.79 $549,024 - $635,208
15,200 Added 5.24%
305,327 $11.2 Million
Q2 2023

Jul 24, 2023

BUY
$36.12 - $41.79 $9.35 Million - $10.8 Million
258,909 Added 829.36%
290,127 $10.6 Million
Q1 2023

May 11, 2023

SELL
$39.39 - $51.28 $858,150 - $1.12 Million
-21,786 Reduced 41.1%
31,218 $1.27 Million
Q4 2022

Feb 06, 2023

SELL
$41.75 - $54.5 $602,410 - $786,380
-14,429 Reduced 21.4%
53,004 $2.72 Million
Q2 2022

Aug 01, 2022

SELL
$46.53 - $55.17 $57,650 - $68,355
-1,239 Reduced 1.8%
67,433 $3.52 Million
Q1 2022

May 09, 2022

SELL
$45.75 - $56.69 $2.01 Million - $2.49 Million
-43,858 Reduced 38.97%
68,672 $3.56 Million
Q4 2021

Feb 08, 2022

BUY
$41.32 - $61.25 $947,137 - $1.4 Million
22,922 Added 25.58%
112,530 $6.57 Million
Q3 2021

Nov 03, 2021

BUY
$39.25 - $50.42 $2.4 Million - $3.08 Million
61,181 Added 215.22%
89,608 $3.86 Million
Q2 2021

Aug 05, 2021

BUY
$35.91 - $40.68 $513,189 - $581,357
14,291 Added 101.1%
28,427 $1.11 Million
Q1 2021

May 06, 2021

SELL
$33.49 - $37.77 $483,830 - $545,663
-14,447 Reduced 50.54%
14,136 $512,000
Q4 2020

Feb 02, 2021

BUY
$33.47 - $42.56 $150,648 - $191,562
4,501 Added 18.69%
28,583 $1.05 Million
Q3 2020

Nov 05, 2020

BUY
$31.75 - $37.25 $191,420 - $224,580
6,029 Added 33.4%
24,082 $879,000
Q2 2020

Aug 10, 2020

BUY
$30.12 - $36.54 $300,808 - $364,924
9,987 Added 123.82%
18,053 $590,000
Q1 2020

May 11, 2020

SELL
$27.03 - $38.62 $6,865 - $9,809
-254 Reduced 3.05%
8,066 $263,000
Q3 2019

Nov 14, 2019

SELL
$32.49 - $42.13 $21,800 - $28,269
-671 Reduced 7.46%
8,320 $299,000
Q2 2019

Aug 14, 2019

BUY
$36.98 - $41.52 $38,681 - $43,429
1,046 Added 13.17%
8,991 $390,000
Q1 2019

May 13, 2019

SELL
$37.5 - $41.2 $451,312 - $495,842
-12,035 Reduced 60.24%
7,945 $336,000
Q4 2018

Feb 13, 2019

SELL
$38.47 - $43.86 $8,155 - $9,298
-212 Reduced 1.05%
19,980 $872,000
Q3 2018

Nov 14, 2018

SELL
$34.47 - $41.81 $181,277 - $219,878
-5,259 Reduced 20.66%
20,192 $887,000
Q2 2018

Aug 14, 2018

BUY
$32.98 - $35.16 $839,373 - $894,857
25,451 New
25,451 $937,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Meitav Dash Investments LTD Portfolio

Follow Meitav Dash Investments LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meitav Dash Investments LTD, based on Form 13F filings with the SEC.

News

Stay updated on Meitav Dash Investments LTD with notifications on news.